prafastatin (Q1240093)

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

(3R,5R)-7-[(1S,2S,6S,8S,8aS)-6-hydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid ^Saesneg

4 Hydref 2016

stereoisomer of ^Saesneg

2 ffynonellau

inferred from InChIKey ^Saesneg

inferred from InChI ^Saesneg

6'-epipravastatin ^Saesneg

1 ffynhonnell

(3S,5S)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid ^Saesneg

inferred from InChI ^Saesneg

1 ffynhonnell

inferred from InChI ^Saesneg

fformwla gemegol

C₂₃H₃₆O₇

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

19 Tachwedd 2016

SMILES

CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

19 Tachwedd 2016

isomeric SMILES ^Saesneg

CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

https://www.whocc.no/atc_ddd_index/?code=C10AA03

19 Tachwedd 2016

defined daily dose ^Saesneg

30 milligram

dull gweini

gweini genau

1 ffynhonnell

cyfeirnod URL

cynhwysyn actif yn

Pravachol ^Saesneg

1 ffynhonnell

RxNorm ^Saesneg

RxNorm ID ^Saesneg

203333

14 Chwefror 2018

World Health Organisation international non-proprietary name ^Saesneg

pravastatin (Saesneg)

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

63618

pravastatin (Saesneg)

4 Hydref 2016

found in taxon ^Saesneg

Penicillium citrinum

1 ffynhonnell

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium ^Saesneg

Aspergillus sclerotiorum ^Saesneg

1 ffynhonnell

Lovastatin Analogues from the Soil-Derived Fungus Aspergillus sclerotiorum PSU-RSPG178. ^Saesneg

clefyd a drinir

hypertriglyceridemia ^Saesneg

1 ffynhonnell

NDF-RT ^Saesneg

NDF-RT

N0000148255

clefyd y rhydwelïau coronaidd

13 Rhagfyr 2016

1 ffynhonnell

NDF-RT ^Saesneg

NDF-RT

N0000148255

13 Rhagfyr 2016

familial hyperlipidemia ^Saesneg

1 ffynhonnell

NDF-RT ^Saesneg

NDF-RT

N0000148255

13 Rhagfyr 2016

1 ffynhonnell

NDF-RT ^Saesneg

13 Rhagfyr 2016

lipedema ^Saesneg

1 ffynhonnell

Drug Indications Extracted from FAERS ^Saesneg

2 Hydref 2018

lewcemia myeloid aciwt

1 ffynhonnell

Drug Indications Extracted from FAERS ^Saesneg

2 Hydref 2018

rare dyslipidemia ^Saesneg

1 ffynhonnell

Drug Indications Extracted from FAERS ^Saesneg

2 Hydref 2018

significant drug interaction ^Saesneg

ciprofibrate ^Saesneg

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

gemffibrosil

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ffenoffibrad

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

(2R)-daptomycin ^Saesneg

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

colchicinum

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

bezafibrate ^Saesneg

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ffenoffibrad

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ciprofibrate ^Saesneg

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

colchicinum

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

(2R)-daptomycin ^Saesneg

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

bezafibrate ^Saesneg

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

clarithromycin

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

clarithromycin

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ciclosporin

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

ciclosporin

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

gemffibrosil

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

established ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

erythromycin

side effect ^Saesneg

rhabdomyolysis ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

erythromycin

side effect ^Saesneg

muscular disease ^Saesneg

1 ffynhonnell

hypothetically ^Saesneg

adweithia'n ffisegol gyda

A reference set of clinically relevant adverse drug-drug interactions ^Saesneg

HMGCR

rôl y pwnc

enzyme inhibitor ^Saesneg

1 ffynhonnell

dynodwr Llawlyfr Ffarmacoleg Ligand

IUPHAR/BPS Guide to PHARMACOLOGY ^Saesneg

2953

17 Awst 2016

Solute carrier organic anion transporter family member 1B1 ^Saesneg

rôl y pwnc

enzyme inhibitor ^Saesneg

1 ffynhonnell

dynodwr Llawlyfr Ffarmacoleg Ligand

IUPHAR/BPS Guide to PHARMACOLOGY ^Saesneg

2953

categori beichiogrwydd Awstralia D

17 Awst 2016

categori beichiogrwydd

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

categori beichiogrwydd Unol Daleithiau America X

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

LiverTox likelihood score ^Saesneg

LiverTox toxicity likelihood category B ^Saesneg

1 ffynhonnell

LiverTox ^Saesneg

https://www.ncbi.nlm.nih.gov/books/n/livertox/Pravastatin

8 Ebrill 2021

cyfeirnod URL

last update ^Saesneg

5 Awst 2017

2 ffynonellau

NDF-RT ^Saesneg

5 Mawrth 2018

15 Mawrth 2018

anticholesteremic agents ^Saesneg

1 ffynhonnell

15 Mawrth 2018

Pravastatin

0 ffynonellau

Identifiers

InChI

InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1

1 ffynhonnell

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

19 Tachwedd 2016

InChIKey ^Saesneg

2 ffynonellau

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

19 Tachwedd 2016

ChEBI release 2020-09-01 ^Saesneg

Rhif Cofrestru CAS

81093-37-0

2 ffynonellau

Global Substance Registration System ^Saesneg

UNII ^Saesneg

KXO2KT9N0G

pravastatin (Saesneg)

19 Tachwedd 2016

InChIKey ^Saesneg

CAS Common Chemistry ^Saesneg

https://commonchemistry.cas.org/detail?cas_rn=81093-37-0

8 Ebrill 2021

cyfeirnod URL

ChemSpider ID ^Saesneg

49398

1 ffynhonnell

ChemSpider ^Saesneg

ChemSpider ID ^Saesneg

49398

Pravastatin (Saesneg)

19 Tachwedd 2016

PubChem CID ^Saesneg

2 ffynonellau

PubChem ^Saesneg

PubChem CID ^Saesneg

pravastatin (Saesneg)

19 Tachwedd 2016

InChIKey

InChIKey ^Saesneg

Reaxys registry number ^Saesneg

4825538

1 ffynhonnell

ChEBI ^Saesneg

ChEBI ID ^Saesneg

63618

pravastatin (Saesneg)

4 Hydref 2016

ChEBI ID ^Saesneg

63618

mapping relation type ^Saesneg

exact match ^Saesneg

2 ffynonellau

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL1144

PRAVASTATIN (Saesneg)

19 Tachwedd 2016

InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1

International Chemical Identifier ^Saesneg

InChI

ChEMBL ID ^Saesneg

CHEMBL1144

1 ffynhonnell

ChEMBL ^Saesneg

ChEMBL ID ^Saesneg

CHEMBL1144

PRAVASTATIN (Saesneg)

19 Tachwedd 2016

SureChEMBL ID ^Saesneg

SCHEMBL1117

2 ffynonellau

inferred from InChIKey ^Saesneg

InChIKey

InChIKey ^Saesneg

UniChem compound ID ^Saesneg

385404

1 ffynhonnell

splash10-00di-0002900000-bd7fd66d793ae64426ff

UniChem ^Saesneg

MassBank accession ID ^Saesneg

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

0 ffynonellau

SPLASH ^Saesneg

0 ffynonellau

splash10-0udi-4809000000-0ed5a8797dfc49ecf5af

0 ffynonellau

splash10-0udi-2900000000-91b125182ce5d90f16ab

0 ffynonellau

splash10-0udi-1900000000-e8fc6384260de93c5aa8

0 ffynonellau

splash10-0udi-1900000000-11e99968bc0ba393b6f9

0 ffynonellau

splash10-0udi-4900000000-0e4265e6dc1468c1471d

0 ffynonellau

splash10-00di-0002900000-8795ee00dded0ef8be48

0 ffynonellau

splash10-0udi-3709000000-aa45be15af0471c0a46e

0 ffynonellau

splash10-0udi-2900000000-5617409991f5c58e5130

0 ffynonellau

splash10-0udi-2900000000-2bf5c13979a639625d1c

0 ffynonellau

splash10-0udi-2900000000-9a233e521607e82ab7a0

0 ffynonellau

splash10-0udi-0900000000-2083dfbb67bf2b03ccf9

0 ffynonellau

splash10-0uk9-0009000000-4b2c09a295ba7f3ce41b

0 ffynonellau

splash10-00di-0607900000-e57e263ad3f74bfda195

0 ffynonellau

dynodwr HSDB

8368

1 ffynhonnell

Hazardous Substances Data Bank ^Saesneg

28 Hydref 2019

Pravastatin (Saesneg)

10 Mai 2021

DSSTox substance ID ^Saesneg

DTXSID6023498

2 ffynonellau

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Saesneg

InChIKey

InChIKey ^Saesneg

DSSTOX compound identifier ^Saesneg

DTXCID003498

0 ffynonellau

LiverTox ID ^Saesneg

Pravastatin

0 ffynonellau

EC number ^Saesneg

689-360-3

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.216.225

27 Rhagfyr 2018

+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]-heptanoic acid (Saesneg)

dyfyniad

CAS no.: 81093-37-0 (Saesneg)

ECHA Substance Infocard ID ^Saesneg

100.216.225

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.216.225

27 Rhagfyr 2018

+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(S)-2-methylbutyryloxy]-1,2,6,7,8,8a-hexahydro-1-naphthyl]-heptanoic acid (Saesneg)

dyfyniad

CAS no.: 81093-37-0 (Saesneg)

Cod yr ATC

C10AA03

1 ffynhonnell

Dynodwr Drugbank (Alberta)

DrugBank ^Saesneg

00175